E
Novavax, Inc. NVAX
$7.95 -$0.43-5.13%
Recommendation
Sell
Prev Close
$8.38
Volume
5,014,261
Avg Vol (90D)
4,528,203
Market Cap
$1.35B
Dividend & Yield
--
52-Week Range
$3.81 - $23.86
P/E (TTM)
--
EPS (TTM)
-$1.32
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Novavax (NVAX, $8.38) entered Uptrend as Momentum indicator ascends above 0 level on Mar 17, 2025
3/18/2025 - Tickeron - Technical Analysis
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
3/17/2025 - Zacks Investment Research
Novavax (NVAX, $7.99) entered Downtrend as Momentum indicator drops below 0 level on Mar 14, 2025
3/15/2025 - Tickeron - Stocks
Monaco Asset Management SAM Buys 222,500 Shares of Novavax, Inc. (NASDAQ:NVAX)
3/14/2025 - Ticker Report
Novavax, Inc. (NASDAQ:NVAX) Given Consensus Recommendation of "Hold" by Analysts
3/14/2025 - Ticker Report
Novavax call volume above normal and directionally bullish
3/13/2025 - TipRanks Financial Blog
Novavax call volume above normal and directionally bullish
3/13/2025 - The Fly
Some Novavax, Inc. (NASDAQ:NVAX) Analysts Just Made A Major Cut To Next Year's Estimates
3/12/2025 - Simply Wall St
Novavax, Inc. (NVAX) Leerink Partners 2025 Global Healthcare Conference (Transcript)
3/11/2025 - SeekingAlpha
Novavax, Inc. (NVAX) Leerink Partners 2025 Global Healthcare Conference (Transcript)
3/11/2025 - Seeking Alpha: Transcripts
Novavax Announces Changes to Board of Directors
3/11/2025 - GuruFocus
Novavax announces Young to retire as Chair of the Board, McGlynn to succeed
3/11/2025 - The Fly
Novavax Announces Changes to Board of Directors
3/11/2025 - PR Newswire
Novavax (NASDAQ:NVAX) Shares Up 6.7% - Time to Buy?
3/9/2025 - Ticker Report
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Analysts
3/9/2025 - MarketBeat
Novavax (NASDAQ:NVAX) Stock Price Up 6.7% - Here's Why
3/8/2025 - MarketBeat
Novavax (NVAX, $8.34) entered Uptrend as Momentum indicator ascends above 0 level on Mar 07, 2025
3/8/2025 - Tickeron - Stocks
Novavax, Inc. (NASDAQ:NVAX) Shares Bought by Oppenheimer & Co. Inc.
3/8/2025 - MarketBeat
Novavax (NasdaqGS:NVAX) Shares Rise 11% Following Q4 2024 Earnings Improvement
3/7/2025 - Simply Wall St
B. Riley Brokers Decrease Earnings Estimates for Novavax
3/6/2025 - MarketBeat
Novavax, Inc. (NVAX) TD Cowen 45th Annual Health Care Conference (Transcript)
3/4/2025 - SeekingAlpha
Novavax, Inc. (NVAX) TD Cowen 45th Annual Health Care Conference (Transcript)
3/4/2025 - Seeking Alpha: Transcripts
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
3/4/2025 - Zacks Investment Research
Novavax (NVAX, $7.87) entered Downtrend as Momentum indicator drops below 0 level on Mar 03, 2025
3/4/2025 - Tickeron - Stocks
Novavax (NVAX, $7.87) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 3, 2025
3/4/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$682.16M
EBITDA (TTM)
-$183.44M
EBIT (TTM)
-$231.93M
Net Income (TTM)
-$187.50M
Balance Sheet
Total Assets (Q)
$1.56B
Total Debt (Q)
$263.47M
Total Liabilities (Q)
$2.18B
Book Value Per Share (Q)
-$3.89
Cash Flow
Cash from Operations (TTM)
-$87.26M
Cash from Investing (TTM)
-$204.04M
Cash from Financing (TTM)
$260.58M
Net Change in Cash (TTM)
-$38.52M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.21
7-Day Total Return
-4.68%
30-Day Total Return
-5.69%
60-Day Total Return
-11.67%
90-Day Total Return
-12.83%
Year to Date Total Return
-7.23%
1-Year Total Return
54.67%
2-Year Total Return
32.94%
3-Year Total Return
-90.34%
5-Year Total Return
-25.35%
52-week Low
Apr 18, 2024 - $3.81
52-week High
Jun 06, 2024 - $23.86
Valuation
Market Cap
$1.35B - Small Cap
Enterprise Value
$688.23M
Price/Sales (TTM)
1.97
Price/Book (Q)
-2.15
Dividends and Shares
Shares Outstanding
160.24M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
global.novavax.com
Phone Number
240 268 2000
Address
700 Quince Orchard Road
Gaithersburg, MD 20878
Country
United States
Year Founded
1987
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and... more
NASDAQ 03/18/2025 4:00PM Eastern Quotes delayed
Weiss Ratings